Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase Activity
- PMID: 35991572
- PMCID: PMC9382028
- DOI: 10.3389/fgene.2022.928884
Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase Activity
Abstract
Ubiquitin-like containing plant homeodomain Ring Finger 1 (UHRF1) protein is recognized as a cell-cycle-regulated multidomain protein. UHRF1 importantly manifests the maintenance of DNA methylation mediated by the interaction between its SRA (SET and RING associated) domain and DNA methyltransferase-1 (DNMT1)-like epigenetic modulators. However, overexpression of UHRF1 epigenetically responds to the aberrant global methylation and promotes tumorigenesis. To date, no potential molecular inhibitor has been studied against the SRA domain. Therefore, this study focused on identifying the active natural drug-like candidates against the SRA domain. A comprehensive set of in silico approaches including molecular docking, molecular dynamics (MD) simulation, and toxicity analysis was performed to identify potential candidates. A dataset of 709 natural compounds was screened through molecular docking where chicoric acid and nystose have been found showing higher binding affinities to the SRA domain. The MD simulations also showed the protein ligand interaction stability of and in silico toxicity analysis has also showed chicoric acid as a safe and nontoxic drug. In addition, chicoric acid possessed a longer interaction time and higher LD50 of 5000 mg/kg. Moreover, the global methylation level (%5 mC) has been assessed after chicoric acid treatment was in the colorectal cancer cell line (HCT116) at different doses. The result showed that 7.5 µM chicoric acid treatment reduced methylation levels significantly. Thus, the study found chicoric acid can become a possible epidrug-like inhibitor against the SRA domain of UHRF1 protein.
Keywords: SRA domain; UHRF1; chicoric acid; global methylation (5 mC); molecular docking; molecular dynamics simulation.
Copyright © 2022 Awal, Nur, Al Khalaf, Rehan, Ahmad, Hosawi, Choudhry and Khan.
Conflict of interest statement
AA is employed by the Translational Research Institute, Hamad Medical Corporation, Qatar. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures








Similar articles
-
The finger loop of the SRA domain in the E3 ligase UHRF1 is a regulator of ubiquitin targeting and is required for the maintenance of DNA methylation.J Biol Chem. 2019 Oct 25;294(43):15724-15732. doi: 10.1074/jbc.RA119.010160. Epub 2019 Sep 3. J Biol Chem. 2019. PMID: 31481468 Free PMC article.
-
Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development.Oncotarget. 2018 May 25;9(40):26243-26258. doi: 10.18632/oncotarget.25425. eCollection 2018 May 25. Oncotarget. 2018. PMID: 29899856 Free PMC article. Review.
-
Structure-based screening of chemical libraries to identify small molecules that are likely to bind with the SET and RING-associated (SRA) domain of Ubiquitin-like, PHD and Ring Finger-containing 1 (UHRF1).BMC Res Notes. 2020 May 24;13(1):254. doi: 10.1186/s13104-020-05103-4. BMC Res Notes. 2020. PMID: 32448288 Free PMC article.
-
The UHRF1 protein stimulates the activity and specificity of the maintenance DNA methyltransferase DNMT1 by an allosteric mechanism.J Biol Chem. 2014 Feb 14;289(7):4106-15. doi: 10.1074/jbc.M113.528893. Epub 2013 Dec 24. J Biol Chem. 2014. PMID: 24368767 Free PMC article.
-
Coordinated Dialogue between UHRF1 and DNMT1 to Ensure Faithful Inheritance of Methylated DNA Patterns.Genes (Basel). 2019 Jan 18;10(1):65. doi: 10.3390/genes10010065. Genes (Basel). 2019. PMID: 30669400 Free PMC article. Review.
Cited by
-
Mechanistic insights into UHRF1‑mediated DNA methylation by structure‑based functional clarification of UHRF1 domains (Review).Oncol Lett. 2023 Nov 2;26(6):542. doi: 10.3892/ol.2023.14129. eCollection 2023 Dec. Oncol Lett. 2023. PMID: 38020304 Free PMC article. Review.
-
Virtual Screening and In Vitro Experimental Verification of LuxS Inhibitors for Escherichia coli O157:H7.Microbiol Spectr. 2023 Feb 21;11(2):e0350222. doi: 10.1128/spectrum.03502-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36809060 Free PMC article.
-
Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1.Molecules. 2023 Aug 10;28(16):5997. doi: 10.3390/molecules28165997. Molecules. 2023. PMID: 37630248 Free PMC article. Review.
-
Epigenetics-targeted drugs: current paradigms and future challenges.Signal Transduct Target Ther. 2024 Nov 26;9(1):332. doi: 10.1038/s41392-024-02039-0. Signal Transduct Target Ther. 2024. PMID: 39592582 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources